A first-of-its-kind, federally funded clinical trial has shown it’s possible to identify breast cancer
A drug used in medical abortions could help prevent women at high risk of
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced
Monday, June 30, 2025 NIH study could help to guide clinical recommendations for hormone
A new triple therapy for aggressive, advanced breast cancer slows the progression of the
A new treatment approach can significantly improve survival rates for patients with aggressive, inherited
In neighborhoods across America, women face a daunting threat from a federal practice that,
